Clinical Trial Update: Mid-HDF Randomized Controlled Study on Outcome [NA]

View source ↗

Summary

Update on the outcomes of a Mid-HDF randomized controlled study in patients with End-Stage Renal Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: End Stage Renal Disease | NA | Status: UNKNOWN